cyclopentane has been researched along with Acute Lymphoid Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barredo, JC; DeSalvo, J; Leclerc, GJ; Leclerc, GM; Swords, RT; Zheng, S | 1 |
| Carol, H; Gorlick, R; Houghton, PJ; Kang, MH; Keir, ST; Kolb, EA; Lock, R; Maris, JM; Morton, CL; Reynolds, CP; Smith, MA; Smith, PG; Wu, J; Yu, J | 1 |
2 other study(ies) available for cyclopentane and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cyclopentanes; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Eukaryotic Initiation Factor-2; Heterografts; Humans; Mice; NEDD8 Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; TOR Serine-Threonine Kinases; Ubiquitins; Unfolded Protein Response | 2016 |
Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Cyclopentanes; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; NEDD8 Protein; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sarcoma; Tumor Cells, Cultured; Ubiquitins; Xenograft Model Antitumor Assays | 2012 |